Edwards Lifesciences Corp banner

Edwards Lifesciences Corp
F:EWL

Watchlist Manager
Edwards Lifesciences Corp Logo
Edwards Lifesciences Corp
F:EWL
Watchlist
Price: 75.34 EUR -0.58% Market Closed
Market Cap: €45.4B

Wall St Price Targets

EWL Price Forecast
Based on 32 analysts

+18% Upside
from €75.34 today

Edwards Lifesciences Corp (EWL)’s 12-month stock price forecast through September 2027 has a consensus target of €89.11, implying 18% upside. The forecast is based on price targets from 32 Wall Street analysts.

EWL Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for EWL yet.

Edwards Lifesciences Corp Competitors:
Price Targets

Financial forecasts

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is EWL's stock price target?
Price Target
89.11 EUR

According to Wall Street analysts, the average 1-year price target for EWL is 89.11 EUR with a low forecast of 74.26 EUR and a high forecast of 99.91 EUR.

What is the Revenue forecast for Edwards Lifesciences Corp?
Projected CAGR
10%

Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 5 years is 10%.

What is the Gross Profit forecast for Edwards Lifesciences Corp?
Projected CAGR
10%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 5 years is 10%.

What is the Operating Income forecast for Edwards Lifesciences Corp?
Projected CAGR
13%

Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 5 years is 13%.

What is the Pre-Tax Income forecast for Edwards Lifesciences Corp?
Projected CAGR
28%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 28%.

What is the Net Income forecast for Edwards Lifesciences Corp?
Projected CAGR
20%

Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 5 years is 20%.

Back to Top